Phenotypes of staphylococcal resistance to macrolides, lincosamides and streptogramin B (MLS) in a Turkish University Hospital

Zentralblatt fur Bakteriologie

Volumn 289, Issue 8, 2000, Pages 827-833

  Tunçkanat, Ferda ^a   Arikan, Sevtap ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; GENE EXPRESSION; GENETIC SCREENING; LINCOSAMIDE; MACROLIDE; MICROBIAL SENSITIVITY TEST; MICROORGANISM SCREENING; MIKAMYCIN B; PHENOTYPE; SPECTINOMYCIN; TRANSPOSON; TURKEY;

EID: 1642602521     PISSN: 09348840     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0934-8840(00)80009-2     Document Type: Article

References (24)

1. Duval, J.: Evolution and epidemiology of MLS resistance. J. Antimicrob. Chemother. 16, Suppl. A (1985) 137-149
2. Eady, E. A., J. I. Ross, and J. H. Cove: Multiple mechanisms of erythromycin resistance. J. Antimicrob. Chemother. 26 (1990) 461-471
3. Eady, E. A., J. L Ross, J. L. Tipper, C. E. Walters, J. H. Cove, and W. C. Noble: Distribution of genes encoding erythromycin ribosomal methylases and an erythromycin efflux pump in epidemiologically distinct groups of staphylococci. J. Antimicrob. Chemother. 31 (1993) 211-217
4. th Congress of Chemotherapy, Florence, Italy (P. Periti and G. G. Grassi eds.), pp. 918-919. American Society for Microbiology, Washington DC (1982)
5. Jenssen, W. D., S. Thakker-Varia, D. T. Dubin, and M. P. Weinstein: Prevalence of macrolides-lincosamides-streptogramin B resistance and erm gene classes among clinical strains of staphylococci and streptococci. Antimicrob. Agents Chemother. 31 (1987) 883-888
6. Lacey, R. W., N. Keyworth, and C. Lincoln: Staphylococci in the UK: a review. J. Antimicrob. Chemother. 14 Suppl. D (1984) 19-25
7. Lampson, B. C. and J. T. Parisi: Naturally occurring Staphylococcus epidermidis expressing constitutive-macrolide-lincosamide-streptogramin B resistance contains a deleted attenuator. J. Bacteriol. 166 (1986) 479-483
8. Leclercq, R. and P. Courvalin: Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrob. Agents Chemother. 35 (1991) 1267-1272
9. Leclercq, R. and P. Courvalin: Intrinsic and unusual resistance to macrolide, lincosamide, and streptogramin antibiotics in bacteria. Antimicrob. Agents Chemother. 35 (1991) 1273-1276
10. Leski, T., D. Oliveira, K. Trzcinski, I. Santos Sanches, M. Aires de Sousa, W. Hryniewicz, and H. de Lencastre: Clonal distribution of methicillin-resistant Staphylococcus aureus in Poland. J. Clin. Microbiol. 36 (1998) 3532-3539
11. Mitsuashi, S. and M. Inoue: Resistance to macrolides and lincomycins. In: Antimicrobial drug resistance (L. E. Bryan ed.) Academic Press. Inc., Orlando, Fla. (1984)
12. Murphy, E.: Nucleotide sequence of erm A, a macrolide-lincosamide-streptogramine B determinant in Staphylococcus aureus. J. Bacteriol. 162 (1985) 633-640
13. National Committee for Clinical Laboratory Standards: Performance Standards for Antimicrobial Disk Susceptibility Tests, 6th edition, Approved Standard M2-A6. National Committee for Clinical Laboratory Standards, Villanova, Pa (1997)
14. Thakker-Varia, S., W. D. Jenssen, L. Moon-McDermott, M. P. Weinstein, and D. T. Dubin: Molecular epidemiology of macrolides-lincosamides-streptogramin B resistance in Staphylococcus aureus and coagulase-negative staphylococci. Antimicrob. Agents Chemother. 31 (1987) 735-743
15. Weisblum, B. and V. Demohn: Erythromycin-inducible resistance in Staphylococcus aureus: survey of antibiotic classes involved. J. Bacteriol. 98 (1969) 447-452
16. Weisblum, B., C. Siddhikol, C. J. Lai, and V. Demohn: Erythromycin-inducible resistance in Staphylococcus aureus: Requirements for induction. J. Bacteriol. 106 (1971) 835-847
17. Weisblum, B.: Inducible erythromycin resistance in bacteria. Br. Med. Bull. 40 (1984) 47-53
18. Weisblum, B.: Inducible resistance to macrolides, lincosamides and streptogramin type B antibiotics: the resistance phenotype, its biological diversity, and structural elements that regulate expression. A review. J. Antimicrob. Chemother. 16, Suppl. A (1985) 63-90
19. Weisblum, B.: Erythromycin resistance by ribosome modification. Antimicrob. Agents. Chemother. 39 (1995) 577-585
20. Weisblum, B.: Insights into erythromycin action from studies of its activity as inducer of resistance. Antimicrob. Agents Chemother. 39 (1995) 797-805
21. Westh, H., A. M. Knudsen, A. Gottschau, and V. T. Rosdahl: Evolution of Staphylococcus aureus resistance to erythromycin in Denmark, 1959 to 1988: comparison with erythromycin-susceptible strains. J. Hosp. Infect 18 (1991) 23-34
22. Westh, H., A. M. Knudsen, A. Gottschau, and V. T. Rosdahl: Evolution of Staphylococcus aureus resistance to erythromycin in Denmark, 1959 to 1988: correlations between characteristics of erythromycin-resistant bacteremia strains. J. Hosp. Infect. 18 (1991) 35-43
23. Westh, H., D. M. Hougaard, J. Vuust, and V. T. Rosdahl: erm genes in erythromycin-resistant Staphylococcus aureus and coagulase-negative staphylococci. APMIS 103 (1995) 225-232
24. Wiedemann, B. and M. Kresken: The incidence and development of resistance in Staphylococcus aureus from three European countries. J. Antimicrob. Chemother. 14 Suppl. D (1984) 27-44